Currently, there are 51.50M common shares owned by the public and among those 42.75M shares have been available to trade.
Insiders at the company have transacted a total of 22 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 16 of these insider trades were purchases, accounting for 555,000 shares. Insider sales of the common stock occurred on 6 occasions, with total insider shares sold totaling 65,796 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 2.4900, down -53.13%. The company’s stock has a 5-day price change of -55.32% and 50.00% over the past three months. GTHX shares are trading -31.15% year to date (YTD), with the 12-month market performance down to -70.55% lower. It has a 12-month low price of $1.08 and touched a high of $5.00 over the same period. GTHX has an average intraday trading volume of 6.02 shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -48.33%, -37.50%, and -11.57% respectively.
Institutional ownership of G1 Therapeutics Inc (NASDAQ: GTHX) shares accounts for 21.80% of the company’s 51.50M shares outstanding.
It has a market capitalization of $108.86M and a beta (3y monthly) value of 1.77. The earnings-per-share (ttm) stands at -$1.47. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.94% over the week and 12.16% over the month.
Analysts forecast that G1 Therapeutics Inc (GTHX) will achieve an EPS of $The Growth Fund of America Clas for the current quarter, $66.37 for the next quarter and $Mutual Fund for Type. The lowest estimate earnings-per-share for the quarter is $Garrett Motion Inc. while analysts give the company a high EPS estimate of $GUIDED THERAPEUTICS INC. Comparatively, EPS for the current quarter was $Genetron Holdings Limited a year ago. Earnings per share for the fiscal year are expected to increase by 71.49%, and 10.64% over the next financial year.
Looking at the support for the GTHX, a number of firms have released research notes about the stock. JP Morgan stated their Neutral rating for the stock in a research note on January 30, 2023, with the firm’s price target at $7-$10.
